cancer treatment

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  

cancer treatment
Jun 28, 2025, 15:30 | Blog
Ira Mellman Outlines Vision for Cancer Immunotherapy in New Interview with Nature Reviews - PICI
Parker Institute for Cancer Immunotherapy shared  a post on LinkedIn: "The first wave of immunotherapies…
Jun 28, 2025, 14:32 | Blog
Toral Shah Shared Highlights From NIHR and WCRF Event on The Role of Diet and Exercise in Oncology
Toral Shah, Nutritional Scientist, Integrative Oncology and Functional Medicine practitioner at Toral Shah Integrative Health, shared…
Jun 27, 2025, 07:19 | Drugs
Tovorafenib (Ojemda): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Tovorafenib is a targeted cancer therapy that works by blocking specific proteins involved in cancer…
Jun 25, 2025, 07:53 | Oncolibrary
FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-Mutated Non-Small Cell Lung Cancer
On June 23, 2025, the U.S. Food and Drug Administration (FDA) granted accelerated approval to…
Jun 25, 2025, 06:14 | Oncolibrary
How Chemotherapy Affects Cancer and Normal Cells: Mechanisms, Side Effects and Long-Term Risks
Chemotherapy remains a cornerstone of systemic cancer treatment, with its primary mechanism rooted in the…
Jun 23, 2025, 06:04 | Blog
Vivek Subbiah: Reflecting on a Successful ASCO and the Bright Future of Cancer Treatment
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Jun 21, 2025, 15:34 | Blog
Bernd Kasper: We Are One Step Closer to the Approval of the First And Only Therapy with Marketing Authorization in the EU for Desmoid Tumors
Bernd Kasper, Senior Attending Physician at University Hospital Mannheim, shared a post on LinkedIn: "What…
Jun 19, 2025, 16:57 | Blog
David Planchard: We Need to Work Together to Develop The Wave of New Treatments That Is Coming For Our Patients
David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic…
Jun 19, 2025, 04:29 | Oncolibrary
Bladder Cancer Cure Rate: What Patients Need to Know in 2025
Understanding the bladder cancer cure rate is crucial for patients and caregivers navigating this common…
Jun 14, 2025, 13:45 | Blog
ESMO Living Guidelines on Renal Cell Carcinoma Are Out
ESMO shared a post on X: "ESMO Living Guidelines on Renal Cell Carcinoma v1.1: New…
Jun 13, 2025, 11:08 | Drugs
Pemigatinib (Pemazyre): What patients need to know?
Pemigatinib is a targeted cancer medication designed to treat specific types of cancers caused by…
Jun 13, 2025, 04:16 | Drugs
Pemigatinib (Pemazyre): Uses in Cancer, Side effects, Dosage, Expectation and more
Pemigatinib is a type of targeted cancer treatment that works by blocking abnormal FGFR (fibroblast…
Jun 12, 2025, 15:26 | Science
Sergio Cifuentes Canaval Shares Key Insights on Clinical Trial Barriers Related to Race and Older Age
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared a post on Linkedin:…
Jun 11, 2025, 11:32 | Insight
Goutham Sunny: A very important editorial on tailoring treatment for older individuals with favourable breast cancer
Goutham Sunny, Former Resident Doctor at The Gujarat Cancer and Research Institute, shared a post…
Jun 11, 2025, 05:15 | Insight
Melanoma Advances at Sylvester Comprehensive Cancer Center: New Trials, Therapies, and Diagnostics
Sylvester Comprehensive Cancer Center shared a post on LinkedIn: "Doctors and researchers at Sylvester are…
Jun 10, 2025, 11:37 | Drugs
Futibatinib (Lytgobi): What patients need to know?
Futibatinib is a targeted cancer treatment developed by Taiho Oncology. In 2022, it received FDA…
Jun 10, 2025, 03:46 | Drugs
Futibatinib (Lytgobi): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Futibatinib is a targeted cancer therapy that inhibits FGFR2, a protein involved in tumor growth…
Jun 9, 2025, 09:07 | Blog
John Crown Highlights Tebentafusp Milestone and Access Disparity in Uveal Melanoma
John Crown, Chair of Translational Cancer Medicine at Dublin City University, shared a post on X:…
Jun 8, 2025, 08:29 | Blog
Moawia Mohammed Ali Elhassan: Cancer treatment amid armed conflict - Challenges and urgent needs in Sudan
Moawia Mohammed Ali Elhassan, Associate Professor at the University of Gezira, shared a post on…
Jun 1, 2025, 13:02 | Oncolibrary
CheckMate 214 Trial Final 9-Year Results at ASCO 2025: Nivolumab Plus Ipilimumab Continues to Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Presented by Dr. Robert J. Motzer at ASCO 2025, the final 9-year follow-up results from…
Jun 1, 2025, 03:54 | Oncolibrary
POLCAGB Results at ASCO 2025: Concurrent Chemoradiation Plus Chemotherapy Improves Survival and Resection Outcomes in Locally Advanced Gallbladder Cancer
Presented at ASCO 2025 by Dr. Reena Engineer from Tata Memorial Centre, POLCAGB Phase III…
May 28, 2025, 05:38 | Drugs
Sorafenib (Nexavar): What patients need to know?
Sorafenib is a targeted cancer treatment taken as a tablet. It has been approved by…
May 27, 2025, 21:28 | Blog
Tingting Zhang: Join to discuss patient partnering in managing chronic toxicities of cancer treatment
Tingting Zhang, Patient Advocate, shared a post by MASCC, adding: "Join us to discuss patient…
May 23, 2025, 10:02 | Drugs
Eribulin (Halaven): What patients need to know?
Eribulin is a chemotherapy drug primarily used for treating metastatic breast cancer and liposarcoma, a…
May 23, 2025, 08:08 | Drugs
Eribulin (Halaven): Uses in Cancer, Side effects, Dosage, Expectations, and more
Eribulin is an anticancer chemotherapy agent classified as a microtubule dynamics inhibitor and structurally related…
May 20, 2025, 09:22 | Drugs
Pluvicto (177Lu-PSMA-617): What patients need to know?
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a targeted radioligand therapy used for treating advanced…
May 19, 2025, 18:28 | Blog
Cancer treatment has evolved dramatically - FDA Oncology
FDA Oncology shared on X: "Cancer treatment has evolved dramatically! Then: Surgery and radiation were…
May 18, 2025, 11:49 | Blog
How Cancer Treatment Has Transformed with Modern Therapies - FDA Oncology
FDA Oncology shared a post on X: "Cancer treatment has evolved dramatically! Then, Surgery and…
May 18, 2025, 05:14 | Drugs
Pluvicto (177Lu-PSMA-617): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a targeted radioligand therapy used to treat advanced…
May 16, 2025, 13:21 | Oncolibrary
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
On May 15, 2025, the U.S. Food and Drug Administration (FDA) approved retifanlimab-dlwr (Zynyz, Incyte…
May 15, 2025, 01:25 | Blog
Kashyap Patel: Emerging Health Concern - The Intersection of COVID-19 and Cancer Diagnoses
Kashyap Patel, Medical Director of the International Oncology Network, Past President at Community Oncology Alliance,…
May 14, 2025, 18:42 | Oncolibrary
FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer
On May 14, 2025, the U.S. Food and Drug Administration (FDA) granted accelerated approval for…
May 14, 2025, 14:44 | Science
Neoadjuvant PARP Inhibitor Scheduling in BRCA1 and BRCA2 Related Breast Cancer
Wafik El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director…
May 12, 2025, 07:42 | Blog
American Association for Cancer Research (AACR): Advancing the Frontiers of Cancer Science Since 1907
In 1907, a small group of eleven visionary scientists gathered in Washington, D.C. to take…
May 11, 2025, 13:51 | Oncolibrary
FDA Grants Accelerated Approval to Avutometinib and Defactinib for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer: RAMP 201 trial results
On May 8, 2025, the U.S. Food and Drug Administration (FDA) granted accelerated approval to…
May 9, 2025, 12:42 | Drugs
Penpulimab: What patients need to know?
Penpulimab, also known by its generic name penpulimab-kcqx, is a newly FDA-approved immunotherapy for certain…
May 9, 2025, 09:15 | Drugs
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
​Penpulimab is a novel humanized monoclonal antibody that targets PD-1 (programmed death-1), a key immune…
May 8, 2025, 18:12 | Opinion
Erman Akkus highlights new platinum derivatives Aurkine 16 and 18 for cancer treatment
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "New platinum…
May 7, 2025, 08:18 | Science
Luis Diaz: The Inspiring Story of Kelly Spill highlights the Transformative Potential of Advancements in Cancer Treatment
Luis Diaz, Head of the Division of Solid Tumor Oncology within the Department of Medicine at…
May 6, 2025, 10:13 | Cancer Types
Thyroid Cancer: Symptoms, Causes, Stages, Diagnosis, and Treatment
Thyroid cancer is a type of cancer that begins in the thyroid gland, a small,…
May 5, 2025, 13:03 | Science
Multicenter Analysis of High-Dose Chemotherapy Regimens For The Treatment of Patients With Refractory or Recurrent GCTs
ESMO Open shared a post on X: "Multicenter analysis of high-dose chemotherapy regimens for the…
May 5, 2025, 10:26 | Science
Jasmin Hundal: Can a WhatsApp-based remote exercise program improve the quality of life for older adults with cancer?
Jasmin Hundal, Hematology Oncology Fellow at Cleveland Clinic, shared an article on LinkedIn: "Can a WhatsApp-based…
May 5, 2025, 10:03 | Science
Top Clinical Trials at ESTRO 2025: Organ Preservation and Quality of life after Total Neoadjuvant Therapy for LA Rectal Cancer
Fresh from the stage at ESTRO 2025 - Gani Cihan presented the the impact of…
May 5, 2025, 09:34 | Science
Elvina Almuradova: From Dose-Finding to Dose-Optimization in Early-Phase Oncology Clinical Trials
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an article…
May 1, 2025, 08:58 | Drugs
Vimseltinib (Romvimza): Uses in Cancer, Side effects, Dosage, Expectations, and more
Vimseltinib is an oral kinase inhibitor that selectively targets the colony-stimulating factor 1 receptor (CSF1R).…
May 1, 2025, 06:15 | Blog
Congratulations to our newest MASCC-Designated Centers of Excellence in Supportive Care in Cancer - MASCC
The Multinational Association of Supportive Care in Cancer (MASCC) shared a post on LinkedIn: "Congratulations…
Apr 30, 2025, 13:49 | Drugs
Cabozantinib: What patients need to know?
Cabozantinib is a targeted therapy used to treat various types of cancer. This oral medication…
Apr 30, 2025, 07:31 | Drugs
Cabozantinib: Uses in Cancer, Side effects, Dosage, Expectation, and more
Cabozantinib is an oral tyrosine kinase inhibitor used to treat various cancers. It targets multiple…
Apr 25, 2025, 15:26 | Blog
SIOP Europe and CCI-E joint position for the revision of the EU pharmaceutical legislation
SIOP Europe shared a post on Facebook: "Unlocking new possibilities with what we already have.…
Apr 25, 2025, 14:11 | Blog
Cognitive Impairment and Accelerated Brain Aging: The Insult of Cancer and Cancer Treatment on the Brain - IOWG
Integrative Oncology Working Group, shared a post on LinkedIn: "Sunday April 27, 2025 1PM EST.…
Apr 25, 2025, 09:57 | Blog
What to Expect at the AACR Annual Meeting 2025: Key Highlights and Must-Attend Sessions​
The AACR Annual Meeting 2025, taking place from April 25–30 at McCormick Place Convention Center…
Apr 25, 2025, 05:55 | Drugs
Durvalumab (Imfinzi): What patients need to know?
Durvalumab is a cancer immunotherapy designed to help the immune system recognize and attack cancer…
Apr 24, 2025, 13:53 | Drugs
Durvalumab (Imfinzi): Uses in Cancer, Side effects, Dosage, Expectations and More
​Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that targets the programmed death-ligand…
Apr 23, 2025, 22:49 | Blog
Supporting Families in Pediatric Oncology in South Africa - Childhood Cancer International
Childhood Cancer International shared a post on LinkedIn: "In South Africa, CHOC Childhood Cancer Foundation…
Apr 23, 2025, 10:33 | Blog
Herbert Loong: It was a real pleasure meeting so many lung cancer friends
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared on LinkedIn:…
Apr 23, 2025, 10:15 | Drugs
Binimetinib (Mektovi): What patients need to know?
Binimetinib, sold under the brand name Mektovi, is an FDA-approved oral medication used to treat…
Apr 22, 2025, 15:25 | Drugs
Binimetinib (Mektovi): Uses in Cancer, Side effects, Dosage, Expectations, and more
Binimetinib is an oral targeted cancer therapy that belongs to a class of drugs known…
Apr 22, 2025, 02:45 | Blog
Daniel Flora: This Is What the Ideal Cancer Treatment Looks Like
Daniel Flora, Medical Director of Oncology Research at St. Elizabeth Healthcare, shared a post on…
Apr 21, 2025, 23:52 | Blog
Carmen Monge-Montero: Rasika Bombatkar on a Surprising Side Effect of Cancer Treatment
Carmen Monge-Montero, Researcher and patient advocate at Youth Cancer Europe, shared a post on LinkedIn:…
Apr 20, 2025, 11:06 | Drugs
Loqtorzi (Toripalimab): What patients need to know?
Toripalimab (Loqtorzi) is a PD-1 inhibitor, a type of immune checkpoint inhibitor that works by…
Apr 19, 2025, 16:23 | Blog
Elvina Almuradova: Olaparib improved ORR and PFS in BRCA-mutated PSR ovarian cancer, but no OS benefit
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Apr 19, 2025, 13:12 | Drugs
Toripalimab (Loqtorzi): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Toripalimab is a PD-1 inhibitor, a type of immune checkpoint inhibitor that works by blocking…
Apr 19, 2025, 01:00 | Blog
Norman Ng: Joanne Chiu discusses the remarkable advancements in cancer treatment and the potential for long-term survival
Norman Ng, Director of Patient Advocacy and Public Affairs at Healthcare Thinkers, shared a post…
Apr 17, 2025, 17:02 | Blog
Daniel Flora: New targeted therapy combined with chemotherapy for metastatic colon cancer
Daniel Flora, Medical Director of Oncology Research at St. Elizabeth Healthcare, shared a post on…
Apr 17, 2025, 07:35 | Drugs
Selpercatinib (Retevmo): What patients need to know?
Selpercatinib (Retevmo) is a targeted therapy to treat cancers driven by RET gene alterations. This…
Apr 16, 2025, 17:55 | Blog
Amol Akhade: Should CDK4/6 inhibitors be standard in early HR+/HER2– breast cancer?
Amol Akhade, Senior Medical and Hemato-Oncologist based in Mumbai, India, shared a post on LinkedIn:…
Apr 16, 2025, 09:40 | Immune Oncology
What Are the Signs That Immunotherapy Is Working?
Immunotherapy has revolutionized cancer treatment by activating the body’s immune system to recognize and destroy…
Apr 15, 2025, 17:59 | Blog
New guidance for managing gastrointestinal symptoms from cancer treatment - Digestive Cancers Europe
Digestive Cancers Europe shared a post on LinkedIn: "Managing Gastrointestinal symptoms from Cancer Treatment: New…
Apr 15, 2025, 15:10 | Blog
Samantha Siegel: Onco-Primary Approach to Symptoms in Survivorship
Samantha Siegel, Director of Cancer Survivorship at The Permanente Medical Group, shared a post on…
Apr 15, 2025, 09:30 | Blog
Online guidance for sports after cancer treatment - Antoni van Leeuwenhoek
Antoni van Leeuwenhoek shared a post on LinkedIn: "Online guidance for sports after cancer treatment…
Apr 15, 2025, 01:57 | Blog
Proposed cuts to medical research funding threaten to delay progress in clinical trials - Fight Colorectal Cancer
Fight Colorectal Cancer shared a post on LinkedIn: "Proposed cuts to medical research funding threaten…
Apr 14, 2025, 16:49 | Blog
Antonio Giordano’s Novel Work Offers New Hope in the Fight Against Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Dr. Antonio Giordano’s novel work on…
Apr 12, 2025, 15:58 | Oncolibrary
FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial
April 11, 2025 — The U.S. Food and Drug Administration (FDA) has approved the combination…
Apr 12, 2025, 11:00 | Immune Oncology
Can Immunotherapy Make Cancer Worse? When Immunotherapy Stops Working
Immunotherapy is a form of cancer treatment that stimulates the body’s immune system to recognize…
Apr 11, 2025, 02:26 | Drugs
Enhertu (Trastuzumab deruxtecan): What patients need to know?
Cancer treatment has advanced significantly, and one of the most promising breakthroughs is Trastuzumab deruxtecan.…
Apr 10, 2025, 14:00 | Drugs
Trastuzumab deruxtecan (Enhertu): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Trastuzumab deruxtecan (Enhertu) is a smart drug that targets HER2-positive cancer cells, delivering a potent…
Apr 10, 2025, 11:00 | Blog
Mary Nassiri’s experience of running a marathon during her cancer treatment - ICR
The Institute of Cancer Research shared a post on LinkedIn: " 'During my cancer treatment,…
Apr 9, 2025, 15:57 | Cancer Types
Ocular Melanoma: Symptoms, Causes, Stages, Diagnosis and Treatment
Ocular melanoma is a rare but serious type of cancer that arises from melanocytes within…
Apr 6, 2025, 13:44 | Celebrities
Cynthia Nixon's Breast Cancer Journey: How She Went Against, Survived, and More
Cynthia Nixon is an accomplished American actress, activist, and politician best known for her role…
Apr 4, 2025, 13:43 | Drugs
Sotorasib (Lumakras): What Patients need to know?
Sotorasib (brand name: Lumakras) is an innovative targeted therapy that has changed the landscape of…
Apr 4, 2025, 11:24 | Blog
Adriana Kahn and Philippos Costa contribute to advancing cancer treatment at Yale Cancer Center
Yale Cancer Center shared a post on LinkedIn: “For international medical professionals, Yale Cancer Center…
Apr 4, 2025, 11:03 | Drugs
Sotorasib (Lumakras): Uses in Cancer: Side effects: Dosage: Expectation and more
Sotorasib is a groundbreaking KRAS G12C inhibitor and the first targeted therapy for this mutation.…
Apr 3, 2025, 20:19 | Blog
Childhood Cancer International Calls for Support to Fund Life-Saving Treatment in Kenya
Childhood Cancer International shared a post on LinkedIn: "Cancer treatment isn’t guaranteed for all children.…
Apr 3, 2025, 12:43 | Drugs
How Much Does it Cost to Approve a Drug? EMA vs. FDA Regulations and Timelines
Cancer treatments are among the most groundbreaking and urgently needed medical advancements today. However, behind…
Apr 3, 2025, 09:29 | Science
Yan Leyfman: Ammonia - A Hidden Obstacle in Cancer Immunotherapy
Yan Leyfman, Co-founder and executive director of MedNews Week, shared an article by Joanna Domagala, et al.…
Apr 3, 2025, 08:53 | Drugs
Tian Zhang and Petros Grivas discussed best practices for Metastatic Urothelial Carcinoma Therapy
Tian Zhang, Associate Director of Clinical Research at Simmons Comprehensive Cancer Center and Director of…
Apr 3, 2025, 04:43 | Insight
Can engineered bacteria revolutionize cancer treatment? - Cancer Research Institute
Cancer Research Institute (CRI) shared a post on LinkedIn: "Can engineered bacteria revolutionize cancer treatment?…
Apr 1, 2025, 18:37 | Blog
Binay Shah: Three Timely Levers to help bridge growing gap in Cancer Care
Binay Shah, President at Binaytara, shared a post on LinkedIn: "Despite unprecedented advances in cancer…
Apr 1, 2025, 08:18 | Insight
Clinical Mondays: An Exciting Approach Towards Cancer Treatment - The Babak Lab
The Babak Lab shared a post on LinkedIn: "Clinical Mondays: An Exciting Approach Towards Cancer…
Mar 31, 2025, 10:38 | Insight
Rasha Aboelhassan: It's truly wonderful to discover new skills in yourself
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn about a recent…
Mar 31, 2025, 09:48 | Blog
Hadieh Eslampanah: Norouz reminds us of renewal, generosity, and strengthening our connections
Hadieh Eslampanah, Director of International Development and Communications Department at MAHAK Pediatric Cancer Treatment and…
Mar 30, 2025, 15:41 | Blog
New NCI Funding Opportunity to Address Cancer-Related Financial Hardship to Improve Patient Outcomes
NCI Division of Cancer Control and Population Sciences shared a post on LinkedIn: "New Funding…
Mar 30, 2025, 14:01 | Cancer Types
Melanoma (Skin Cancer): Symptoms, Causes, Stages, Diagnosis and Treatment
Skin cancer is one of the most common forms of cancer worldwide, with melanoma being…
Mar 29, 2025, 20:20 | Blog
Benjamin L. Ebert: We know the importance and impact of having access to the best cancer treatment
Benjamin L. Ebert, President and CEO at Dana-Farber Cancer Institute, shared Dana-Farber Cancer Institute's post…
Mar 29, 2025, 18:03 | Blog
Marina Puchinskaya: It was an incredible lecture from ELCC 25
Marina Puchinskaya, Oncologist at "Kravira" Medical Centre, shared ESMO's post on LinkedIn: "It was an…
Mar 29, 2025, 17:00 | Blog
Antonio Passaro: What a time to be in thoracic oncology
Antonio Passaro, Medical Director at IEO European Institute of Oncology, shared on LinkedIn: "What a…
Mar 29, 2025, 06:23 | Blog
UICC - The Growing Global Threat of Antimicrobial Resistance in Cancer Care
Union for International Cancer Control (UICC) posted on LinkedIn: "Antimicrobial Resistance (AMR) is a growing…
Mar 28, 2025, 10:50 | Blog
Julia's Brave Battle Against Leukemia: A Story of Hope and Progress - St. Baldrick's Foundation
St. Baldrick's Foundation posted on LinkedIn: "Six-year-old Julia’s bright smile can light up any room.…
Mar 27, 2025, 13:34 | Blog
Dennis Slamon and Sujuan Ba on HER2 Cancers - NFCR
National Foundation for Cancer Research (NFCR) shared a post on LinkedIn: "In Episode 3 of…
Mar 27, 2025, 12:41 | Blog
Understanding Lung Cancer Clinical Trials: Free Webinar This Friday - Lung Cancer Europe
Lung Cancer Europe shared on LinkedIn: "Reminder: Understanding Lung Cancer Clinical Trials - Free Webinar…
All: 890 Posts: 1 - 100
Special Coverage